trump glp 1 medicare Pres. Donald announced that starting July 1, 2026, patients will be able to access GLP-1 weight-loss medications such as Ozempic for a $50 monthly copay through a new short-term Centers JUST IN: The Trump administration
Description
Methods In this open-label, single-center, casecontrol pilot study, patients with IIH (pwIIH) and a body mass index (BMI) of 30 kg/m 2 were offered to receive a GLP-1-RA (semaglutide, liraglutide) in addition to the usual care weight management (UCWM)
J Atheroscler Thromb 2016;23:1831
Emerging evidence suggests GLP-1RAs may help in: Alzheimer Disease Reduced neuroinflammation Improved neuronal survival Potential slowing of cognitive decline Parkinson Disease Neuroprotective effects Reduced oxidative stress Improved neuronal signaling This area may redefine future neuroendocrine therapeutics
11 Liraglutide (Victoza) is a potent GLP-1RA that secured FDA approval in 2010
Pereira MJ, Lundkvist P, Kamble PG, Lau J, Martins JG, Sjstrm CD, et al
